Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Terminal Care | 2 | 2020 | 46 | 1.070 |
Why?
|
| Hospice Care | 1 | 2020 | 26 | 0.690 |
Why?
|
| Home Care Services | 1 | 2020 | 72 | 0.650 |
Why?
|
| Extracorporeal Membrane Oxygenation | 6 | 2016 | 291 | 0.620 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2024 | 304 | 0.550 |
Why?
|
| Heart Transplantation | 6 | 2016 | 350 | 0.480 |
Why?
|
| Infant, Newborn | 15 | 2024 | 2729 | 0.460 |
Why?
|
| Coronary Care Units | 1 | 2012 | 8 | 0.410 |
Why?
|
| Aspergillus | 1 | 2012 | 52 | 0.390 |
Why?
|
| Continuity of Patient Care | 1 | 2012 | 52 | 0.390 |
Why?
|
| Hospital Mortality | 6 | 2021 | 409 | 0.390 |
Why?
|
| Postoperative Complications | 4 | 2024 | 1018 | 0.390 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2012 | 171 | 0.370 |
Why?
|
| Aspergillosis | 1 | 2012 | 125 | 0.370 |
Why?
|
| Gastrostomy | 1 | 2011 | 55 | 0.370 |
Why?
|
| Quality of Health Care | 1 | 2012 | 184 | 0.360 |
Why?
|
| Adrenal Insufficiency | 1 | 2010 | 18 | 0.360 |
Why?
|
| Norwood Procedures | 1 | 2011 | 57 | 0.360 |
Why?
|
| Retrospective Studies | 17 | 2024 | 6124 | 0.350 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2010 | 91 | 0.350 |
Why?
|
| Preoperative Care | 1 | 2011 | 167 | 0.340 |
Why?
|
| Heart Diseases | 1 | 2012 | 211 | 0.340 |
Why?
|
| Hemodynamics | 1 | 2010 | 263 | 0.320 |
Why?
|
| Infant | 13 | 2024 | 3575 | 0.320 |
Why?
|
| Heart Defects, Congenital | 2 | 2012 | 584 | 0.300 |
Why?
|
| Child | 14 | 2021 | 6849 | 0.300 |
Why?
|
| Child, Preschool | 13 | 2021 | 3879 | 0.290 |
Why?
|
| Palliative Care | 2 | 2020 | 185 | 0.270 |
Why?
|
| Acute Kidney Injury | 2 | 2024 | 291 | 0.260 |
Why?
|
| Heart-Assist Devices | 3 | 2016 | 151 | 0.250 |
Why?
|
| Down Syndrome | 2 | 2016 | 91 | 0.250 |
Why?
|
| Parkinson Disease | 2 | 2017 | 141 | 0.240 |
Why?
|
| Tertiary Care Centers | 2 | 2017 | 76 | 0.240 |
Why?
|
| Furosemide | 1 | 2024 | 11 | 0.230 |
Why?
|
| Diuretics | 1 | 2024 | 28 | 0.230 |
Why?
|
| Respiration, Artificial | 3 | 2024 | 291 | 0.230 |
Why?
|
| Nitric Oxide | 1 | 2006 | 253 | 0.230 |
Why?
|
| Treatment Outcome | 8 | 2024 | 5178 | 0.230 |
Why?
|
| Male | 20 | 2024 | 25454 | 0.220 |
Why?
|
| Female | 20 | 2024 | 26576 | 0.220 |
Why?
|
| Humans | 26 | 2024 | 49929 | 0.220 |
Why?
|
| Central Venous Catheters | 1 | 2023 | 25 | 0.220 |
Why?
|
| Hypoplastic Left Heart Syndrome | 2 | 2016 | 95 | 0.210 |
Why?
|
| Catheterization, Central Venous | 1 | 2023 | 84 | 0.210 |
Why?
|
| Length of Stay | 3 | 2024 | 624 | 0.200 |
Why?
|
| Inflammation | 1 | 2006 | 603 | 0.190 |
Why?
|
| Adolescent | 9 | 2021 | 6417 | 0.180 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2021 | 15 | 0.180 |
Why?
|
| Terminally Ill | 1 | 2020 | 13 | 0.180 |
Why?
|
| Brain Diseases | 1 | 2021 | 80 | 0.180 |
Why?
|
| Heart Failure | 2 | 2015 | 505 | 0.170 |
Why?
|
| Arkansas | 4 | 2012 | 1990 | 0.160 |
Why?
|
| Risk Factors | 7 | 2017 | 3605 | 0.160 |
Why?
|
| Critical Care | 1 | 2020 | 214 | 0.150 |
Why?
|
| Dopamine Agonists | 1 | 2017 | 9 | 0.140 |
Why?
|
| Time Factors | 3 | 2015 | 2891 | 0.140 |
Why?
|
| Hypokinesia | 1 | 2017 | 6 | 0.140 |
Why?
|
| Waiting Lists | 1 | 2016 | 55 | 0.140 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2017 | 167 | 0.130 |
Why?
|
| Young Adult | 4 | 2014 | 4031 | 0.130 |
Why?
|
| Tracheostomy | 1 | 2016 | 71 | 0.130 |
Why?
|
| Registries | 2 | 2024 | 523 | 0.130 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2015 | 39 | 0.120 |
Why?
|
| Heart Arrest | 1 | 2016 | 150 | 0.120 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 24 | 0.120 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2015 | 53 | 0.120 |
Why?
|
| Dystonia | 1 | 2014 | 10 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 99 | 0.120 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2015 | 179 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2012 | 463 | 0.110 |
Why?
|
| Vena Cava, Inferior | 1 | 2013 | 79 | 0.110 |
Why?
|
| Parvoviridae Infections | 1 | 2012 | 20 | 0.100 |
Why?
|
| Parvovirus B19, Human | 1 | 2012 | 17 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2012 | 39 | 0.100 |
Why?
|
| Organizational Objectives | 1 | 2012 | 33 | 0.100 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2012 | 6 | 0.100 |
Why?
|
| Professional-Family Relations | 1 | 2012 | 44 | 0.100 |
Why?
|
| Models, Organizational | 1 | 2012 | 57 | 0.100 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 55 | 0.100 |
Why?
|
| Isoantibodies | 1 | 2012 | 27 | 0.100 |
Why?
|
| Tachycardia, Ectopic Junctional | 1 | 2011 | 4 | 0.100 |
Why?
|
| DNA, Viral | 1 | 2012 | 133 | 0.100 |
Why?
|
| Myocarditis | 1 | 2012 | 45 | 0.100 |
Why?
|
| Health Care Surveys | 1 | 2012 | 174 | 0.100 |
Why?
|
| HLA Antigens | 1 | 2012 | 53 | 0.100 |
Why?
|
| Amiodarone | 1 | 2011 | 22 | 0.100 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 138 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 1182 | 0.100 |
Why?
|
| Laparotomy | 1 | 2011 | 35 | 0.090 |
Why?
|
| Fundoplication | 1 | 2011 | 19 | 0.090 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2011 | 81 | 0.090 |
Why?
|
| Proteasome Inhibitors | 1 | 2012 | 104 | 0.090 |
Why?
|
| Boronic Acids | 1 | 2012 | 182 | 0.090 |
Why?
|
| Pyrazines | 1 | 2012 | 187 | 0.090 |
Why?
|
| Hospitals, Pediatric | 1 | 2012 | 234 | 0.090 |
Why?
|
| Tissue Donors | 1 | 2012 | 111 | 0.090 |
Why?
|
| Comprehension | 1 | 2012 | 113 | 0.090 |
Why?
|
| Graft Rejection | 1 | 2012 | 168 | 0.090 |
Why?
|
| Adrenal Cortex Function Tests | 1 | 2010 | 5 | 0.090 |
Why?
|
| Tetralogy of Fallot | 1 | 2011 | 81 | 0.090 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2010 | 31 | 0.090 |
Why?
|
| Program Evaluation | 1 | 2012 | 349 | 0.090 |
Why?
|
| Telemedicine | 1 | 2017 | 465 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2012 | 259 | 0.090 |
Why?
|
| Herpesviridae Infections | 1 | 2010 | 53 | 0.090 |
Why?
|
| Hydrocortisone | 1 | 2010 | 107 | 0.090 |
Why?
|
| Patient Discharge | 1 | 2012 | 318 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2012 | 566 | 0.080 |
Why?
|
| Weight Gain | 1 | 2011 | 230 | 0.080 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 281 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 508 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 994 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2011 | 170 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 349 | 0.080 |
Why?
|
| Aged | 4 | 2017 | 9449 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 3138 | 0.080 |
Why?
|
| Critical Illness | 1 | 2010 | 297 | 0.070 |
Why?
|
| Follow-Up Studies | 4 | 2015 | 2177 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 907 | 0.070 |
Why?
|
| Middle Aged | 4 | 2017 | 12293 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2006 | 64 | 0.070 |
Why?
|
| Deep Brain Stimulation | 2 | 2017 | 43 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2006 | 104 | 0.060 |
Why?
|
| Jugular Veins | 1 | 2023 | 31 | 0.060 |
Why?
|
| ROC Curve | 1 | 2024 | 225 | 0.060 |
Why?
|
| Catheters, Indwelling | 1 | 2023 | 56 | 0.050 |
Why?
|
| Necrosis | 1 | 2023 | 175 | 0.050 |
Why?
|
| Edema | 1 | 2023 | 68 | 0.050 |
Why?
|
| Adult | 3 | 2014 | 13356 | 0.050 |
Why?
|
| Survival Rate | 2 | 2016 | 905 | 0.050 |
Why?
|
| Incidence | 2 | 2016 | 986 | 0.050 |
Why?
|
| Hypoxia, Brain | 1 | 2021 | 14 | 0.050 |
Why?
|
| Cerebral Infarction | 1 | 2021 | 36 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2021 | 155 | 0.050 |
Why?
|
| Brain Edema | 1 | 2021 | 41 | 0.040 |
Why?
|
| Cerebral Hemorrhage | 1 | 2021 | 97 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2021 | 548 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2015 | 1403 | 0.040 |
Why?
|
| Logistic Models | 1 | 2021 | 896 | 0.040 |
Why?
|
| Ohio | 1 | 2017 | 39 | 0.040 |
Why?
|
| Subthalamic Nucleus | 1 | 2017 | 12 | 0.040 |
Why?
|
| Hand | 1 | 2017 | 50 | 0.030 |
Why?
|
| Movement | 1 | 2017 | 82 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2017 | 123 | 0.030 |
Why?
|
| Patient Selection | 1 | 2016 | 254 | 0.030 |
Why?
|
| Age of Onset | 1 | 2015 | 108 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2015 | 32 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 670 | 0.030 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2015 | 45 | 0.030 |
Why?
|
| Pallidotomy | 1 | 2014 | 1 | 0.030 |
Why?
|
| Time | 1 | 2014 | 26 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2015 | 143 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 956 | 0.030 |
Why?
|
| Azygos Vein | 1 | 2013 | 11 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 2013 | 59 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2016 | 660 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2014 | 121 | 0.030 |
Why?
|
| Texas | 1 | 2012 | 142 | 0.030 |
Why?
|
| Hospitalization | 1 | 2016 | 663 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2012 | 170 | 0.020 |
Why?
|
| Peritoneal Dialysis | 1 | 2012 | 32 | 0.020 |
Why?
|
| Morbidity | 1 | 2012 | 128 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 456 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 953 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2012 | 259 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 1255 | 0.020 |
Why?
|
| Heart | 1 | 2012 | 336 | 0.020 |
Why?
|
| Myocardium | 1 | 2012 | 443 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 820 | 0.020 |
Why?
|
| Comorbidity | 1 | 2010 | 610 | 0.020 |
Why?
|
| Quality of Life | 1 | 2014 | 838 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 692 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 1957 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1092 | 0.020 |
Why?
|
| United States | 1 | 2012 | 4883 | 0.010 |
Why?
|